Oral insulin capsules will replace insulin injections
Oramed Pharmaceuticals Company from Israeli has reported the successful test of insulin capsules helping to control diabetes. As Xinhua notes, a drug known as ORMD-0801 may become the first oral form of insulin.
The drug, developed by Oramed and designed for patients with type 2 diabetes, has been tested on 269 patients. As it turned out, there was a significant decrease in hemoglobin A1C after treatment (a key clinical measure for controlling blood sugar).
The company has reported that the therapy with the new drug gave an excellent safety profile, without serious side effects. In addition, during the 90 days of the study, no weight gain in patients was observed.